Renaissance Technologies’s IDEAYA Biosciences IDYA Stock Holding History

Renaissance Technologies’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-357,600	Closed	-$5.86M	–	3703
2025 Q1	$5.86M	Buy	357,600 +73,333	+26%	+$1.56M	0.01%	1336
2024 Q4	$7.31M	Buy	284,267 +113,902	+67%	+$3.22M	0.01%	1198
2024 Q3	$5.4M	Buy	170,365 +61,040	+56%	+$2.31M	0.01%	1396
2024 Q2	$3.84M	Buy	+109,325	New	+$4.33M	0.01%	1471
2022 Q2	–	Sell	-196,537	Closed	-$2.2M	–	4385
2022 Q1	$2.2M	Buy	+196,537	New	+$2.9M	﹤0.01%	2171
2021 Q4	–	Sell	-29,600	Closed	-$755K	–	4044
2021 Q3	$755K	Sell	29,600 -39,000	-57%	-$911K	﹤0.01%	2699
2021 Q2	$1.44M	Buy	68,600 +7,900	+13%	+$162K	﹤0.01%	2465
2021 Q1	$1.43M	Sell	60,700 -78,700	-56%	-$1.52M	﹤0.01%	2426
2020 Q4	$1.95M	Buy	139,400 +4,800	+4%	+$65K	﹤0.01%	2128
2020 Q3	$1.69M	Buy	134,600 +25,500	+23%	+$316K	﹤0.01%	2232
2020 Q2	$1.55M	Buy	+109,100	New	+$860K	﹤0.01%	2317

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Renaissance Technologies's IDYA Position: Q2 2025 in Review

Renaissance Technologies sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 357,600 shares — an estimated $5.86M sold.

Renaissance Technologies first reported a position in IDYA in Q2 2020 and held it in 11 quarters. The position peaked at $7.31M in Q4 2024. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

Renaissance Technologies reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
Renaissance Technologies sold 357,600 IDEAYA Biosciences shares in Q2 2025, an estimated $5.86M.
Renaissance Technologies first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 11 quarters.
Renaissance Technologies's IDEAYA Biosciences position peaked at $7.31M in Q4 2024.
204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.